Conversations with Innovators: Daniel DeAngelo, MD, on Systemic Mastocytosis

2 Views
administrator
administrator
07/09/23

Dr. DeAngelo and colleagues examined the highly potent and KIT-specific, oral inhibitor BLU-285 to treat patients with advanced systemic mastocytosis.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next